Shareholders Sue Cancer-Drug Maker Over $1.7B Roche Deal
Shareholders for California-based cancer-drug maker Ignyta Inc. are alleging that the company has failed to disclose pertinent financial information ahead of a pending $1.7 billion acquisition by Roche Holding AG, in...To view the full article, register now.
Already a subscriber? Click here to view full article